Depressive DisordersMario Maj, Norman Sartorius John Wiley & Sons, 2002 - 489 pagini Be Guided by the Evidence In this new edition of the first volume of the WPA Series, Evidence and Experience in Psychiatry, issues surrounding depressive disorders are examined in a unique and highly informative manner. The six systematic reviews, written by outstanding authors, focus on key topics such as the choice and duration of drug treatment and the cost of depressive disorders. They are accompanied by commentaries giving advice from clinicians of different orientations and countries. This revised and updated volume: * Gives the best available evidence to enable well-informed clinical decision making * Covers developments in diagnosis, therapy, prognosis, economic evaluation and quality improvement * Summarises the evidence and the experience to provide an unbiased and reliable reference point * Comprehensively itemises and evaluates the relevant points This new edition provides insights that will prove invaluable to psychiatrists, psychologists, mental health nurses, managers and policy makers. |
Cuprins
I | 1 |
II | 52 |
III | 54 |
IV | 57 |
V | 59 |
VI | 63 |
VIII | 65 |
X | 68 |
LV | 271 |
LVI | 273 |
LVIII | 276 |
LIX | 278 |
LX | 281 |
LXI | 283 |
LXIII | 286 |
LXVI | 289 |
XI | 71 |
XII | 73 |
XIII | 75 |
XIV | 77 |
XV | 79 |
XVI | 82 |
XVII | 83 |
XIX | 85 |
XX | 89 |
XXI | 129 |
XXII | 131 |
XXIII | 133 |
XXIV | 135 |
XXV | 138 |
XXVII | 140 |
XXVIII | 142 |
XXIX | 144 |
XXX | 146 |
XXXI | 148 |
XXXII | 150 |
XXXIII | 152 |
XXXIV | 155 |
XXXV | 157 |
XXXVI | 159 |
XXXVII | 161 |
XXXVIII | 207 |
XXXIX | 209 |
XL | 212 |
XLI | 214 |
XLII | 216 |
XLIV | 219 |
XLV | 221 |
XLVI | 223 |
XLVII | 226 |
XLIX | 228 |
L | 230 |
LII | 233 |
LIII | 267 |
LIV | 269 |
LXVII | 292 |
LXVIII | 295 |
LXIX | 297 |
LXX | 299 |
LXXI | 304 |
LXXII | 306 |
LXXIV | 309 |
LXXV | 313 |
LXXVI | 364 |
LXXVIII | 366 |
LXXIX | 369 |
LXXX | 371 |
LXXXI | 373 |
LXXXII | 376 |
LXXXIII | 379 |
LXXXIV | 382 |
LXXXV | 384 |
LXXXVI | 386 |
LXXXVII | 388 |
LXXXVIII | 390 |
LXXXIX | 392 |
XC | 394 |
XCI | 396 |
XCII | 398 |
XCIII | 401 |
XCIV | 450 |
XCV | 452 |
XCVI | 456 |
XCVII | 459 |
XCVIII | 461 |
463 | |
465 | |
CIII | 468 |
CIV | 470 |
CV | 472 |
CVI | 474 |
CVIII | 476 |
CIX | 478 |
Alte ediții - Afișează-le pe toate
Termeni și expresii frecvente
acute adults affective disorders amitriptyline anxiety Arch assessment associated behavioral bipolar bipolar disorder Child Adolesc children and adolescents chronic citalopram Clin clinical practice clinical trials clinicians clomipramine cognitive therapy cognitive-behavioural comorbid compared controlled trial cost-effectiveness costs criteria dementia depres depressed mood depressed patients depression in old depressive episode depressive symptoms diagnostic disease dose double-blind drugs DSM-IV dysthymia economic effective efficacy elderly evidence factors fluoxetine follow-up Geriatr HAM-D imipramine inpatients interpersonal interventions major depressive disorder mental disorders mental health mirtazapine moclobemide nefazodone nortriptyline old age onset outcome outpatients paroxetine pharmacotherapy phenelzine physical illness placebo prevalence primary Psychiatry Psychol Psychopharmacol psychosocial psychotherapy randomized rates RCTs recurrent relapse response risk selective serotonin reuptake serotonin serotonin reuptake inhibitors sertraline severe depression sion social somatic SSRIs Stefanis studies subtypes suicide syndrome TCAs Thase treated treatment of depression tricyclic antidepressants venlafaxine